{"id":474005,"date":"2020-03-16T09:58:01","date_gmt":"2020-03-16T09:58:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=474005"},"modified":"2020-03-16T09:58:01","modified_gmt":"2020-03-16T09:58:01","slug":"acute-heart-failure-market-insights-epidemiology-and-market-forecast-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/acute-heart-failure-market-insights-epidemiology-and-market-forecast-2030_474005.html","title":{"rendered":"Acute Heart Failure Market Insights, Epidemiology and Market Forecast 2030"},"content":{"rendered":"
\"Acute<\/a><\/div>\n
DelveInsight’s “Acute Heart failure (AHF) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acute Heart failure (AHF), historical and forecasted epidemiology as well as the Acute Heart failure (AHF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

Albany, US – <\/strong>DelveInsight launched a new report on Acute Heart failure Market Insights, Epidemiology and Market Forecast-2028<\/a><\/p>\n

DelveInsight’s “Acute Heart failure (AHF) – Market Insights, Epidemiology, and Market Forecast-2030<\/strong>” report delivers an in-depth understanding of the Acute Heart failure (AHF), historical and forecasted epidemiology as well as the Acute Heart failure (AHF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

The key fact of the report:<\/strong><\/p>\n

“The patients are predominantly male with a mean age of >70 years, which is consistent with the epidemiology of ischemic heart disease. The in-hospital mortality ranges from four to seven per cent, with a median length of stay between 4 and 11 days in the disease.”<\/span><\/p>\n

Key benefits of the report:<\/strong><\/p>\n

1. Acute Heart failure market report covers a descriptive overview and comprehensive insight of the Acute Heart failure epidemiology and Acute Heart failure market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/span>
2. Acute Heart failure market report provides insights into the current and emerging therapies.<\/span>
3. Acute Heart failure market report provides a global historical and forecasted market covering drug outreach in 7 MM.<\/span>
4. Acute Heart failure market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Acute Heart failure market.<\/span><\/p>\n

Request for sample page<\/strong>: https:\/\/www.delveinsight.com\/sample-request\/acute-heart-failure-ahf-market<\/span><\/p>\n

Acute heart failure can result due to a number of causes, such as allergic reaction, a blood clot in a lung, a complication of cardiopulmonary bypass surgery, heart attack or myocardial infarction, infection, severely irregular heartbeat, etc.<\/strong><\/p>\n

Acute heart failure (AHF)<\/strong>, also known as an acute decompensated heart failure or cardiac failure, is not a single disease entity, but rather a syndrome of the worsening signs and symptoms reflecting an inability of the heart to pump blood at a rate equal to the needs of the body at normal filling pressure.<\/p>\n

The key players in Acute Heart failure market<\/strong> are:
1. Boehringer Ingelheim
2. Novartis
And many others<\/span><\/p>\n

The launch of the emerging therapies<\/strong> is expected to significantly impact the Acute Heart failure treatment<\/strong> scenario in the upcoming years:-<\/span>
Drugs covered<\/span>
1. Empagliflozin<\/span>
2. Sacubitril\/valsartan<\/span>
And many others<\/span><\/p>\n

Request a free sample report<\/strong> @https:\/\/www.delveinsight.com\/sample-request\/acute-heart-failure-ahf-market<\/span><\/p>\n

Table of contents<\/strong><\/p>\n

1. Report Introduction<\/span>
2. Acute Heart Failure Market Overview at a Glance<\/span>
3. Acute Heart Failure Disease Background and Overview<\/span>
4. Acute Heart Failure Epidemiology and Patient Population<\/span>
5. Acute Heart Failure Country-Wise Epidemiology<\/span>
6. United States<\/span>
7. EU–5 Countries<\/span>
7.1. Assumptions and Rationale<\/span>
7.2. Germany<\/span>
7.3. France<\/span>
7.4. Italy<\/span>
7.5. Spain<\/span>
7.6. United Kingdom<\/span>
7.7. Japan<\/span>
8. Acute Heart Failure Treatments and Medical Practices<\/span>
9. Acute Heart Failure Emerging Therapies<\/span>
10. Key Cross Competition<\/span>
10.1. Empagliflozin: Boehringer Ingelheim<\/span>
10.2. Sacubitril\/valsartan: Novartis<\/span>
11. Acute Heart Failure Market Size<\/span>
12. 7MM Acute Heart Failure Country-Wise Market Analysis<\/span>
13. United States Market Size<\/span>
14. EU5 Market Size<\/span>
14.1.Germany Market Size<\/span>
14.2. France Market Size<\/span>
14.3.United Kingdom Market Size<\/span>
14.4. Spain Market Size<\/span>
14.5. Italy Market Size<\/span>
15. Japan Market Size<\/span>
16. Acute Heart Failure Report Methodology<\/span>
17. DelveInsight Capabilities<\/span>
18. Disclaimer<\/span>
19. About DelveInsight<\/span><\/span><\/p>\n

Related Reports: <\/strong><\/p>\n

Acute Heart failure (AHF) – Epidemiology Forecast to 2030<\/span><\/span><\/span><\/a><\/p>\n

Acute Heart failure (AHF) Pipeline Insight, 2020<\/span><\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Ankit Nigam
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 9193216187
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Las Vegas
State:<\/strong> NEVADA 89107
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight’s “Acute Heart failure (AHF) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Acute Heart failure (AHF), historical and forecasted epidemiology as well as the Acute Heart failure (AHF) market trends in the United … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,403,404],"tags":[],"class_list":["post-474005","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/474005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=474005"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/474005\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=474005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=474005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=474005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}